Adults | Children | |
---|---|---|
N episodes = 21,039 | N episodes = 7,107 | |
Gender female % (n) | 55.3 (11,629) | 47.2 (3,353) |
Age in years | ||
Mean ± SD | 45.8 ± 17.8 | 6.9 ± 3.6 |
Min - Max | 17.0–101.8 | 1.1–16.0 |
Age groups % (n) | ||
<5 years | 0.0 (0) | 33.7 (2,394) |
5–16 years | 0.0 (0) | 66.3 (4,713) |
17–59 years | 79.2 (16,666) | 0.0 (0) |
≥60 years | 20.8 (4,373) | 0.0 (0) |
Insurance status at index date % (n) | ||
Statutory Health Insurance | 93.9 (19,765) | 92.2 (6,550) |
Private insurance | 6.1 (1,274) | 7.8 (557) |
Relevant pre-period risk factorsb,c (as defined by STIKO) | ||
Weakened immune system | ||
Cancer treatment (C00-C97) | 1.9 (392) | 0.1 (9) |
HIV/AIDS (B20-B24) | 0.1 (24) | 0 (0) |
Chronic illness | ||
Any chronic disorders of respiratory organs (J45, J46, J44, J38, J35) | 9.5 (1,995) | 22.9 (1,629) |
Any cardiovascular disorders (I10-15, I20-25, I26-I28, I30-I52, Z99.0-Z99.1) | 28.5 (6,003) | 0.8 (55) |
Any cerebrovascular disorders (I60-I69, G45) | 1.9 (397) | 0.1 (5) |
Diabetes and other metabolic diseases (E10-E14) | 8.9 (1,876) | 0.1 (7) |
Hepatic disorders (B15-B19, K70, K75) | 0.5 (114) | 0.1 (6) |
Renal disorders (N17- N19, Z99.2) | 0.1 (196) | <0.1 (1) |
Any neurological disorders (G04-G05, G20-G21,G30, G35, G40-G41) | 1.4 (292) | 0.8 (57) |
Proportion of episodes with at least one of the above mentioned pre-period risk factors plus age ≥60 years in the adult patient group % (n) | 38.8 (8,165) | 24.3 (1,727) |